Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

13.46 +0.17 (+1.28%)
Streaming Delayed Price Updated: 11:50 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million ↗
Acuitas Dumps Entire Stake in SBH Valued at $2.7 Million 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? ↗
Is Mechanics Bancorp Stock a Buy After Investment Firm Acuitas Initiated a Large Position in the Bank? 
Via The Motley Fool
News headline image
AngioDynamics Eyes Growth Despite Tariffs ↗
AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected. 
Via Benzinga
News headline image
Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For October 2, 2025 ↗
 
Via Benzinga
News headline image
What's Next: AngioDynamics's Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Outlook For AngioDynamics ↗
 
Via Benzinga
News headline image
Why Did AngioDynamics Stock Pop Today? ↗
Even 37 years after its founding, AngioDynamics still can't earn a profit. 
Via The Motley Fool
News headline image
What's Fueling The Momentum In AngioDynamics Stock? ↗
Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter. 
Via Benzinga
News headline image
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results ↗
 
Via Benzinga
News headline image
AngioDynamics Inc (NASDAQ:ANGO) Surpasses Q1 Earnings Estimates and Raises Fiscal 2026 Outlook ↗
AngioDynamics (ANGO) beat Q1 FY2026 earnings and revenue estimates, driven by strong Med Tech growth. The company also raised its full-year financial outlook. 
Via Chartmill
News headline image
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus ↗
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
News headline image
S&P 500 Closes At Record High: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗
CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with record S&P 500 level. 
Via Benzinga
Topics Stocks
News headline image
AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday ↗
US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics. 
Via Benzinga
News headline image
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings ↗
 
Via Benzinga
News headline image
Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock ↗
 
Via Benzinga
News headline image
A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why AngioDynamics Stock Popped, Then Dropped Today ↗
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed. 
Via The Motley Fool
Topics Earnings
News headline image
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting ↗
AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says. 
Via Benzinga
Topics World Trade
News headline image
AngioDynamics (ANGO) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Earnings Scheduled For July 15, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Gold Moves Higher; US Private Sector Job Growth Tops Estimates ↗
 
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance ↗
AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth. 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets ↗
The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical... 
Via Stocktwits
News headline image
Earnings Scheduled For April 2, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.